Skip to Content

M2Bio Sciences Inc WUHN Stock Quote

| Rating as of


Morningstar‘s Stock Analysis WUHN

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics WUHN

Company Profile WUHN

Business Description

M2Bio Sciences Inc is a United States-based nutraceutical biotechnology company. It focuses on alternative plant-based cannabinoids and psilocybin medical research that is into the development and commercialization of CBD and mushrooms-based products. The company's brands include Dr. AnnaRx, Medspresso, and Handcrafted Delight. It is also into research with psilocybin that aims to develop new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases.

401 Ryland Street, Ste 200-A
Reno, NV, 89502
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Dec 31, 2012
Fiscal Year End Dec 31, 2021
Employees 3